Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Cabometyx is the third liver cancer drug approved in the past six months.
Rick George credits his spiritual life with seeing him through multiple health crises, including liver cancer.
A new study examines the clinical and economic impact of new direct-acting antivirals.
Liver cancer rates and deaths have doubled in the United States, Canada, Australia and United Kingdom.
This is according to an analysis of nearly 5,000 Italians recently treated for the virus.
Hepatitis B and C are declining as causes of liver cancer and liver transplants.
In the past, he was accused of misusing data, showing religious bias and discriminating against gay men and people with HIV.
Those who smoke and have liver cancer but not viral hepatitis did not have such an elevated risk.
Any previous apparent link between direct-acting antivirals, compared with interferon, and liver cancer was likely driven by other factors.
However, no such difference was seen among those with cirrhosis or those whose virus was not well treated.
A brief overview of the differences between hepatitis A, B and C.
Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.
One of the major international conferences on all aspects of liver disease, opened Sunday in Washington, DC.
But curing hepatitis C does lower the risk of liver cancer.
Having either form of viral hepatitis was associated with about a 75 percent increased risk of non–Hodgkin lymphoma in a recent study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.